Biochemical effects of pretreatment with vitamins E and C in rats submitted to intrastriatal hypoxanthine administration

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1276-1283

  Bavaresco, Caren Serra ^a   Chiarani, Fabria ^a   Kolling, Janaína ^a   Netto, Carlos Alexandre ^a   de Souza Wyse, Angela Terezinha ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antioxidants defenses; Hypoxanthine; Lesch Nyhan; Lipoperoxidation; Na+,K+ ATPase; Vitamins E and C

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; GLUTATHIONE PEROXIDASE; HYPOXANTHINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; LESCH NYHAN SYNDROME; LIPID PEROXIDATION; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CATALASE; CORPUS STRIATUM; DISEASE PROGRESSION; FREE RADICALS; HYPOXANTHINE; LESCH-NYHAN SYNDROME; OXIDATIVE STRESS; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TREATMENT OUTCOME; VITAMIN E;

ANIMALIA; RATTUS;

EID: 40949098557     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.01.008     Document Type: Article

References (65)

1. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
2. +)-ATPase inhibition induced by arginine administration is prevented by vitamins E and C. Neurochem. Res. 28 (2003) 825-829
3. +-ATPase activity in rat striatum by metabolites accumulated in Lesch Nyhan disease. Int. J. Dev. Neurosci. 22 (2004) 11-17
4. +-ATPase activity and some parameters of oxidative stress in rat striatum. Brain Res. 1041 (2005) 198-204
5. +-ATPase, acetylcholinesterase and catalase activities in striatum, hippocampus and cerebral cortex of rats. Int. J. Dev. Neurosci. 24 (2006) 411-417
6. +)-ATPase activity and induces oxidative stress in the rats. Metab. Brain Dis. 22 (2007) 1-11
7. Bavaresco C.S., Chiarani F., Duringon E., Ferro M.M., Cunha C.D., Netto C.A., and Wyse A.T. Intrastriatal injection of hypoxanthine reduces striatal serotonin content and impairs spatial memory performance in rats. Metab. Brain Dis. 22 (2007) 67-76
8. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38 (1995) 357-366
9. Beckman J.S., Liu T.H., Hogan E.L., Freeman B.A., and Hsu C.Y. Oxygen free radicals and xanthine oxidase in cerebral ischemic injury in the rat. Soc. Neurosci. Abstr. 13 (1987) 1498
10. Behl P., Stefurak T.L., and Black S.E. Progress in clinical neurosciences: cognitive markers of progression in Alzheimer's disease. Can. J. Neurol. Sci. 32 (2005) 40-151 (Review)
11. Bickford P.C., Gould T., Briederick L., Chadman K., Pollock A., Young D., Shukitt-Hale B., and Joseph J. Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res. 866 1-2 (2000) 211-277
12. +-stimulated ATPase activity. Anal. Biochem. 157 (1986) 375-380
13. Dasheiff R.M. Benzodiazepinic treatment for Lesch-Nyhan syndrome?. Dev. Med. Child Neurol. 22 (1980) 101-102
14. Delwing D., Bavaresco C.S., Monteiro S.C., Matté C., Netto C.A., and Wyse A.T. Alpha-tocopherol and ascorbic acid prevent memory deficits provoked by chronic hyperprolinemia in rats. Behav. Brain Res. 168 (2006) 185-189
15. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 8 (2002) 47-95 (review)
16. Engelhart M.J., Geerlings M.I., Ruitenberg A., Van Swieten J.C., Hofman A., Witteman J.C., and Breteler M.M. Diet and risk of dementia: does fat matter?-the Rotterdam Study. Neurology 59 (2002) 1915-1921
17. Erecinska M., and Silver I.A. Ions and energy in mammalian brain. Prog. Neurobiol. 7 (1994) 21-29
18. Evelson P., Travacio M., Repetto M., Escobar J., Llesuy S., and Lissi E.A. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch. Biochem. Biophys. 388 (2001) 261-266
19. Fighera M.R., Queiroz C.M., Stracke M.P., Brauer M.C., González-Rodríguez L.L., Frussa-Filho R., Wajner M., and de Mello C.F. Ascorbic acid and alpha-tocopherol attenuate methylmalonic acid-induced convulsions. Neuroreport 10 (1999) 2039-2043
20. Floyd R.A. Antioxidants, oxidative stress and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222 (1999) 236-245
21. Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc. Soc. Exp. Biol. Med. 222 (1999) 196-204 (Review)
22. +-pump in epilepsy. Ann. Neurol. 16 (1984) 128-134
23. Halliwell B. Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem. Soc. Trans. 24 (1996) 1023-1027
24. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006) 1634-1658 (Review)
25. Halliwell B., and Gutteridge J.M. The importance of free radicals and catalytic metal ions in human diseases. Mol. Aspects Med. 8 (1985) 89-193
26. Harkness R.A., McCreanor G.M., and Watts R.W. Lesch-Nyhan syndrome and its pathogenesis: purine concentrations in plasma and in urine with metabolite profiles in CSF. J. Inherit. Metab. Dis. 11 (1988) 239-252
27. Henderson J.F. Possible functions of hypoxanthine-guanine phosphoribosyltransferase and their relation to the biochemical pathology of the Lesch-Nyhan syndrome. Fed. Proc. 27 (1968) 1075-1077
28. Horton J.W. Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology 189 (2003) 75-88
29. Ito Y., Pagano P.J., Tornheim K., Brecher P., and Cohen R.A. Oxidative stress increases glyceraldehyde-3-phosphate dehydrogenase mRNA levels in isolated rabbit aorta. Am. J. Physiol. 270 (1996) 81-87
30. +)-ATPase activity by oxygen free radicals. Neuroreport 7 (1995) 333-337
31. Jinnah H.A., and Friedmann T. Lesch Nyhan disease and it variants. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 2537-2569
32. Jinnah H.A., and Gage F.H. Animal models of Lesch-Nyhan syndrome. Brain Res. Bull. 25 (1990) 467-475
33. Jones D.H., and Matus A.I. Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta 356 (1974) 276-287
34. Kelly F.J. Use of antioxidants in the prevention and treatment of disease. J. Int. Fed. Clin. Chem. 10 (1998) 21-23 (review)
35. Kisch S.J., Fox I.H., Kapur B.M., Lloyd K.G., and Hornykiewicz O. Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan. Brain Res. 336 (1985) 117-123
36. Kourie J.I. Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases. Cell. Mol. Neurobiol. 21 (2001) 173-213
37. Lees G.J. Contributory mechanism in the causation of neurodegenerative disorders. Neuroscience 54 (1993) 287-322
38. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-267
39. Marklund S.L. Product of extracellular-superoxide dismutase catalysis. FEBS Lett. 184 (1985) 237-239
40. Matté C., Durigon E., Stefanello F.M., Cipriani F., Wajner M., and Wyse A.T. Folic acid pretreatment prevents the reduction of Na(+), K(+)-ATPase and butyrylcholinesterase activities in rats subjected to acute hyperhomocysteinemia. Int. J. Dev. Neurosci. 24 (2006) 3-8
41. Matthews W.S., Solan A., Barabas G., and Robey K. Cognitive functioning in Lesch-Nyhan syndrome: a 4-year follow-up study. Dev. Med. Child Neurol. 41 (1999) 260-262
42. Michiels C., Raes M., Toussaint O., and Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 17 (1994) 235-248 (review)
43. Mizuno T. Long-term follow-up of ten patients with Lesch-Nyhan syndrome. Neuropediatrics 17 (1986) 158-161
44. Monteiro S.C., Matté C., Bavaresco C.S., Netto C.A., and Wyse A.T. Vitamins E and C pretreatment prevents ovariectomy-induced memory deficits in water maze. Neurobiol. Learn. Mem. 84 (2005) 192-199
45. Monteiro S.C., Mattos C.B., Scherer E.B., and Wyse A.T. Supplementation with vitamins E plus C or soy isoflavones in ovariectomized rats: effect on the activities of Na(+), K (+)-ATPase and cholinesterases. Metab. Brain Dis. 22 (2007) 156-171
46. Nyhan W.L., Oliver W.J., and Lesch M. A familial disorder or uric acid metabolism and central nervous system function II. J. Pediatr. 67 (1965) 439-444
47. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
48. Oliveira P.J., Rolo A.P., Palmeira C.M., and Moreno A.J. Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: relevance to hypoxia/reoxygenation injury. Cardiovasc. Toxicol. 1 (2001) 205-213
49. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, London
50. Puig J.G., and Mateos F.A. The biochemical basis of HGPRT deficiency. In: Gresser U. (Ed). Molecular Genetics, Biochemistry and Clinical Aspects of inherited Disorders of Purine and Pyrimidine Metabolism (1993), Springer-Verlag, New York 12-26
51. Puig J.G., Jimenez M.L., Mateos F.A., and Fox I.H. Adenine nucleotide turnover in hypoxanthine-guanine phosphoribosyl-transferase: evidence for an increased contribution of purine biosyntheses de novo. Metabolism 38 (1989) 410-418
52. +-ATPase activity. Physiol. Res. 48 (1999) 73-78
53. Rijksen G., Staal G.E.J., Van der Vlist M.J.M., Beerner F.A., Troost J., Gutensohn W., Van Laarhoven J.P.R.M., and De Bruyn C.H.M.M. Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome. Hum. Genet. 57 (1981) 39-47
54. Rosenbloom R.M., Henderson J.F., Caldwell I.C., Kelley W.N., and Seegmiller J.E. Inherited disorder of purine metabolism. JAMA 202 (1967) 175-177
55. Stefanello F.M., Franzon R., Tagliari B., Wannmacher C., Wajner M., and Wyse A.T. Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia. Metab. Brain Dis. 20 (2005) 97-103
56. Travacio M., and Llesuy S. Antioxidant enzymes and their modification under oxidative stress conditions. Free Radic. Res. Latin Am. 48 (1996) 9-13
57. Visser J.E., Smith D.W., Moy S.S., Breese G.R., Friedmann T., Rothstein J.D., and Jinnah H.A. Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. Brain Res. Dev. Brain Res. 133 (2002) 127-139
58. Wendel A. Glutathione peroxidase. Methods Enzymol. 77 (1981) 325-333
59. Wengreen H.J., Munger R.G., Corcoran C.D., Zandi P., Hayden K.M., Fotuhi M., Skoog I., Norton M.C., Tschanz J., Breitner J.C., and Welsh-Bohmer K.A. Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J. Nutr. Health aging 11 (2007) 230-237
60. +-ATPase activity after brain ischemia. Neurochem. Res. 25 (2000) 969-973
61. +)-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem. Res. 27 (2002) 1685-1689
62. Zaidi S.M., and Banu N. Antioxidant potential of vitamins A E and C in modulating oxidative stress in rat brain. Clin. Chim. Acta 340 (2004) 229-333
63. Zarkovic K. 4-Hydroxynonenal and neurodegenerative diseases. Mol. Aspects Med. 24 (2003) 293-303 (review)
64. Zhang X.L., Jiang B., Li Z.B., Hao S., and An L.J. Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by d-galactose. Pharmacol. Biochem. Behav. 88 (2007) 64-72
65. +-ATPase and creatine kinase can be differentially prevented by taurine and vitamins E and C administration in rat striatum in vivo. Biochim. Biophys. Acta 1772 (2007) 563-569